Evidence map›Paper›PMID 26903478›Full record

ArticleIntensive care medicine2016

PF4-heparin antibodies during ECMO: incidence, course, and outcomes.

Florent Laverdure, Virginie Louvain-Quintard, Talna Kortchinsky, Saïda Rezaiguïa-Delclaux, Audrey Imbert, François Stéphan

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Extracorporeal life support in cardiogenic shock: indications and management in current practice.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2018
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Florent LaverdureCardiothoracic Intensive Care Unit, Service de Réanimation Adulte, Hôpital Marie Lannelongue, 133 Avenue de la Résistance, 92350, Le Plessis Robinson, France.
Virginie Louvain-QuintardHemostasis Laboratory, Hôpital Marie Lannelongue, 133 Avenue de la Résistance, 92350, Le Plessis Robinson, France.
Talna KortchinskyCardiothoracic Intensive Care Unit, Service de Réanimation Adulte, Hôpital Marie Lannelongue, 133 Avenue de la Résistance, 92350, Le Plessis Robinson, France.
Saïda Rezaiguïa-DelclauxCardiothoracic Intensive Care Unit, Service de Réanimation Adulte, Hôpital Marie Lannelongue, 133 Avenue de la Résistance, 92350, Le Plessis Robinson, France.
Audrey ImbertCardiothoracic Intensive Care Unit, Service de Réanimation Adulte, Hôpital Marie Lannelongue, 133 Avenue de la Résistance, 92350, Le Plessis Robinson, France.
François StéphanCardiothoracic Intensive Care Unit, Service de Réanimation Adulte, Hôpital Marie Lannelongue, 133 Avenue de la Résistance, 92350, Le Plessis Robinson, France. f.stephan@ccml.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Extracorporeal Membrane OxygenationAnticoagulantsFemaleHeparinHumansImmunoassayMaleMiddle AgedPlatelet Factor 4Prospective StudiesThrombocytopeniaAnticoagulantsHeparinPlatelet Factor 4

Identifiers

PMID26903478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.